• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Microvast Schedules Third Quarter Earnings Call

By: Microvast, Inc. via GlobeNewswire
November 06, 2025 at 07:00 AM EST
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

STAFFORD, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Microvast Holdings, Inc. (NASDAQ: MVST), (“Microvast” or the “Company”), a global leader in advanced battery technologies, will issue a press release reporting its consolidated financial results for the third quarter of 2025 after market close on Monday, November 10, 2025.

Following the earnings press release, Microvast management will host a webcast and earnings conference call at 4:00 p.m. Central Time (5:00 p.m. Eastern Time) to discuss the business results and outlook. The webcast will be accessible from the Events & Presentations tab of Microvast’s investor relations website at https://ir.microvast.com. A replay will be available following the conclusion of the event.

About Microvast

Microvast is a global leader in providing battery technologies for electric vehicles and energy storage solutions. With a legacy of over 19 years, Microvast has consistently delivered cutting-edge battery systems that empower a cleaner and more sustainable future. The company's innovative approach and dedication to excellence have positioned it as a trusted partner for customers around the world. Founded in 2006 in Stafford, Texas, Microvast holds more than 810 patents and patent applications that enable solutions for today’s electrification needs.

For more information, please visit www.microvast.com or follow us on LinkedIn (@microvast).

Contact

Investor Relations
ir@microvast.com

Source: Microvast Holdings, Inc.


Primary Logo

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More
News headline image
ArriVent BioPharma’s ARR-217 Shows 44.8% Response Rate in Colorectal Cancer Study ↗
Today 0:02 EDT
Via MarketBeat
Topics Initial Public Offering
Tickers AVBP
News headline image
Oruka’s ORKA-001 Delivers 61% Complete Skin Clearance in Phase IIb Psoriasis Study ↗
October 26, 2026
Via MarketBeat
Tickers ORKA
News headline image
Incyte Highlights Promising Early Data for ’890 and ’734 in GI Cancers ↗
October 26, 2026
Via MarketBeat
Tickers INCY
News headline image
What Elevra Lithium (ELVR) Said on Its Q1 Earnings Call ↗
October 26, 2026
Via MarketBeat
Topics Earnings Stocks
Tickers ELVR
News headline image
AstraZeneca Highlights Breakthrough Cancer Data at ESMO 2026 Investor Update ↗
October 26, 2026
Via MarketBeat
Topics ETFs
Tickers ARM AZN

Recent Quotes

View More
Symbol Price Change (%)
AMZN  249.09
+1.09 (0.44%)
AAPL  343.91
-3.81 (-1.10%)
AMD  531.28
+14.49 (2.80%)
BAC  50.52
-0.04 (-0.08%)
GOOG  314.19
-3.09 (-0.97%)
META  630.56
-12.06 (-1.88%)
MSFT  532.60
+8.09 (1.54%)
NVDA  216.00
+5.04 (2.39%)
ORCL  126.06
-0.10 (-0.08%)
TSLA  391.62
+19.40 (5.21%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap